Dermatitis News and Research

Latest Dermatitis News and Research

Data on PV-10 combination therapy presented at AACR Annual Meeting

Data on PV-10 combination therapy presented at AACR Annual Meeting

Anacor signs research agreement to discover drug candidates to treat neglected diseases

Anacor signs research agreement to discover drug candidates to treat neglected diseases

arGEN-X advances ARGX-112 into formal preclinical development

arGEN-X advances ARGX-112 into formal preclinical development

Regeneron, Sanofi announce pooled data from Phase 1b trials with dupilumab for atopic dermatitis

Regeneron, Sanofi announce pooled data from Phase 1b trials with dupilumab for atopic dermatitis

Positive results from Anacor’s second of two Phase 3 trials of tavaborole for onychomycosis

Positive results from Anacor’s second of two Phase 3 trials of tavaborole for onychomycosis

Mental health risk increased in children with atopic dermatitis

Mental health risk increased in children with atopic dermatitis

Regeneron fourth quarter total revenues increase to $415 million

Regeneron fourth quarter total revenues increase to $415 million

Oral toxicity is frequent limitation of mTOR therapy

Oral toxicity is frequent limitation of mTOR therapy

Innate lymphoid cells may be new therapeutic target in treating atopic dermatitis

Innate lymphoid cells may be new therapeutic target in treating atopic dermatitis

New insight into eczema’s itch

New insight into eczema’s itch

Selenium supplements do not reduce risk of developing heart disease according to current evidence

Selenium supplements do not reduce risk of developing heart disease according to current evidence

Asthma linked to atopic dermatitis persistence

Asthma linked to atopic dermatitis persistence

Genentech receives FDA approval for new use of Avastin plus chemotherapy to treat mCRC

Genentech receives FDA approval for new use of Avastin plus chemotherapy to treat mCRC

Data from Provectus' PV-10 pre-clinical study on melanoma to be presented at AACR meeting

Data from Provectus' PV-10 pre-clinical study on melanoma to be presented at AACR meeting

Itch-specific nerve cells: an interview with Associate Professor Xinzhong Dong

Itch-specific nerve cells: an interview with Associate Professor Xinzhong Dong

People most often visit doctors because of skin issues, joint disorders and back pain

People most often visit doctors because of skin issues, joint disorders and back pain

Susceptibility genes for bovine digital dermatitis found

Susceptibility genes for bovine digital dermatitis found

Moffitt Cancer Center initiates PV-10 Phase 1 study in melanoma

Moffitt Cancer Center initiates PV-10 Phase 1 study in melanoma

Brake for skin inflammation discovered

Brake for skin inflammation discovered

Pergamum’s DPK-060 Phase II trial on acute external otitis meets primary end-point

Pergamum’s DPK-060 Phase II trial on acute external otitis meets primary end-point

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.